During the past decade, International Dermatology Research, Inc. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "International Dermatology Research, Inc." are "Onychomycosis" (1 trials), "Papulopustular Rosacea" (1 trials), "Plaque-type Psoriasis" (1 trials) and "Psoriasis" (1 trials). Many other conditions were trialed in "International Dermatology Research, Inc." in a lesser frequency.

Most popular intervention types in "International Dermatology Research, Inc." are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Apremilast 10mg" (1 trials), "Apremilast 20mg" (1 trials), "Apremilast 30 mg" (1 trials), "Apremilast 30mg" (1 trials) and "Azelaic acid 15% Gel" (1 trials). Other intervention names were less common.

The vast majority of trials in "International Dermatology Research, Inc." are 3 trials for "All" genders.

Currently, there are NaN active trials in "International Dermatology Research, Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in International Dermatology Research, Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in International Dermatology Research, Inc., 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".